BiotechTube

DSP-0390

Phase 1Active
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

High Grade Glioma

Conditions

High Grade Glioma, Glioblastoma Multiforme

Trial Timeline

Sep 8, 2021 → Oct 31, 2026

NCT ID
NCT05023551

About DSP-0390

DSP-0390 is a phase 1 stage product being developed by Sumitomo Pharma for High Grade Glioma. The current trial status is active. This product is registered under clinical trial identifier NCT05023551. Target conditions include High Grade Glioma, Glioblastoma Multiforme.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT06636162Phase 1Recruiting
NCT05023551Phase 1Active

Competing Products

20 competing products in High Grade Glioma

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
44
GTB-3550 TriKE® Phase I + GTB-3550 TriKE® Phase IIGT BiopharmaPhase 1/2
33
Sepantronium BromideCothera BiosciencePhase 2
44
Edoxaban + ASADaiichi SankyoPhase 3
77
olanzapine plus fosaprepitant-based triple regimen + placebo plus fosaprepitant-based triple regimenSun PharmaceuticalPhase 3
77
Bunazosin + Doxazosin + ValsartinEisaiApproved
85
Pembrolizumab + Pemetrexed + AbemaciclibEli LillyPhase 1
33
dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets + placebo; abiraterone acetate tablets; prednisone tabletsJiangsu Hengrui MedicinePhase 1
33
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
77
SHR3680 + PlaceboJiangsu Hengrui MedicinePhase 3
77
Camrelizumab、Rivoceranib + CamrelizumabJiangsu Hengrui MedicinePhase 2
52
Mirvetuximab soravtansine + CarboplatinAbbViePhase 2
52
HHPG-19K InjectionJiangsu Hengrui MedicinePhase 3
77
Mirvetuximab SoravtansineAbbViePhase 2
52
Zibotentan/Dapagliflozin + DapagliflozinAstraZenecaPhase 2
52
AZD5718 IR tablet + AZD5718 oral suspension + Rosuvastatin tabletAstraZenecaPhase 1
33
Metoprolol Succinate + HydrochlorothiazideAstraZenecaPhase 3
77
Olaparib Pill + AZD6738AstraZenecaPhase 2
52
DAPA/MET XR + DAPA + MET XRAstraZenecaPhase 3
77
Zibotentan/Dapagliflozin + DapagliflozinAstraZenecaPhase 3
77

Other Products from Sumitomo Pharma

BlonanserinApproved
85
Mosapride + domperidoneApproved
85
levalbuterol HCl + albuterol SulfateApproved
85
LurasidoneApproved
85
placebo, isotonic ciclesonide, hypotonic ciclesonideApproved
85